Adaptive Phage Therapeutics Leadership

Q: Who is the founder of Adaptive Phage Therapeutics?

Gregory L. Merril and Carl R. Merril founded Adaptive Phage Therapeutics.

Zippia score 3.9

Adaptive Phage Therapeutics executives

Here are further demographic highlights of the leadership team:

The Adaptive Phage Therapeutics executive team is 9% female and 91% male.
55% of the management team is White.
14% of Adaptive Phage Therapeutics management is Hispanic or Latino.
8% of the management team is Black or African American.

Work at Adaptive Phage Therapeutics?

Share your experience

Rate Adaptive Phage Therapeutics' leaders' effectiveness in guiding the company.

Name & TitleBio

Gregory L. Merril

Board Member

Gregory L. Merril is a Co-Founder & CEO at Adaptive Phage Therapeutics and is based in Washington, D.C.. He attended McDaniel College between 1983 and 1987.

Carl R. Merril

Board Member

Carl Merril is a Co-Founder and CSO at Adaptive Phage Therapeutics and is based in Bethesda, Maryland.

Subhendu Basu Ph.d.

President and COO

Broad experience in BioPharma and Academic settings, spanning Business Development/M&A/Due Diligence, Product Development and Strategy as well as bench science in Immunology /Inflammation and Vaccinology.• Led search, evaluation and scientific diligence for Mergers and Acquisition aligned with corporate strategy and growth plan.• Managed cross-functional scientific diligence teams encompassing Pre-Clinical, Clinical/PV, Quality, Regulatory and Manufacturing/Process Development functions.• Experienced with evaluation of oncology therapeutics and vaccines, infectious disease therapeutics and vaccines and medical devices.• Identify key risks and mitigation to inform valuation, deal structure, milestones and definitive agreements for acquisitions and in-licensing.• Led diligence on successful acquisitions including biologics (vaccine & antibody therapeutics), small molecules (anti-bacterial & anti-viral) and devices that spanned indications in infectious diseases, bleeding disorders and Biodefense.• Portfolio strategy and prioritization• Doctorate in Immunology and Pathology & Ex-faculty at Univ. of Maryland School of Medicine with extensive experience supervising and conducting bench science in Vaccinology, Mucosal Biology and Inflammation

Michael King

Chief Business Officer

Michael King is a Chief Business Officer at Adaptive Phage Therapeutics, Senior Advisor at Akari Therapeutics PLC, and Partner at Hibiscus BioVentures and is based in Gaithersburg, Maryland. He has worked as Interim CFO at PDS Biotechnology Corp, Managing Member at King Street Partners, and Head US Strategy at Sandoz. Michael studied at Columbia Business School, Columbia Graduate School of Business, and Ohio Wesleyan University between 1988 and 1992.

Evan Loh

Board Member

Jana Jensen

Board Member

Jesse Goodman

Board Member

Jonathan Leff

Board Member

Martin Heidecker

Board Member

Raymond D. Martz

Board Member

Do you work at Adaptive Phage Therapeutics?

Does the leadership team provide a clear direction for Adaptive Phage Therapeutics?

Adaptive Phage Therapeutics jobs

Adaptive Phage Therapeutics founders

Name & TitleBio

Gregory L. Merril

Board Member

Gregory L. Merril is a Co-Founder & CEO at Adaptive Phage Therapeutics and is based in Washington, D.C.. He attended McDaniel College between 1983 and 1987.

Carl R. Merril

Board Member

Carl Merril is a Co-Founder and CSO at Adaptive Phage Therapeutics and is based in Bethesda, Maryland.

Adaptive Phage Therapeutics board members

Name & TitleBio

Gregory L. Merril

Board Member

Gregory L. Merril is a Co-Founder & CEO at Adaptive Phage Therapeutics and is based in Washington, D.C.. He attended McDaniel College between 1983 and 1987.

Carl R. Merril

Board Member

Carl Merril is a Co-Founder and CSO at Adaptive Phage Therapeutics and is based in Bethesda, Maryland.

Evan Loh

Board Member

Jana Jensen

Board Member

Jesse Goodman

Board Member

Jonathan Leff

Board Member

Martin Heidecker

Board Member

Raymond D. Martz

Board Member

Adaptive Phage Therapeutics executives FAQs

Who is the founder of Adaptive Phage Therapeutics?

Most in demand jobs

Companies
Maryland
Bethesda, MD
Adaptive Phage Therapeutics
Adaptive Phage Therapeutics Executives

Updated November 18, 2022

Zippia gives an in-depth look into the details of Adaptive Phage Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Adaptive Phage Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Adaptive Phage Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Adaptive Phage Therapeutics. The data presented on this page does not represent the view of Adaptive Phage Therapeutics and its employees or that of Zippia.

Adaptive Phage Therapeutics may also be known as or be related to Adaptive Phage Therapeutics, Adaptive Phage Therapeutics, Inc and Adaptive Phage Therapeutics, Inc.